Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1192
interventional 1010
Observational 163
Registry 19

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 267
Drug|placebo 192
Device 166
Other 89
Procedure 54
Biological 50
Device|Other 29
Biological|placebo 20
Behavioral 18
Dietary Supplement 14
Drug|Other 14
Dietary Supplement|placebo 13
Device|Procedure 11
Biological|Other 8
Device|placebo 7
Drug|Procedure 7
Biological|Procedure 6
Other|placebo 5
Device|Drug 4
Biological|Drug 3
Dietary Supplement|Drug 3
Behavioral|Other 2
Combination Product|Other 2
Combination Product|Procedure 2
Diagnostic Test 2
Dietary Supplement|Other 2
Drug|Other|placebo 2
Drug|placebo|Procedure 2
Genetic|placebo 2
Behavioral|Device 1
Biological|Device|Drug|Procedure 1
Biological|Diagnostic Test|Drug 1
Biological|Drug|placebo 1
Combination Product 1
Device|Other|Procedure 1
Diagnostic Test|Drug 1
Diagnostic Test|Drug|Other 1
Dietary Supplement|Drug|placebo 1
Drug|Genetic 1
Drug|Other|Procedure 1
Genetic 1
Other|Procedure 1
placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 271
NA 62
France 43
China 35
Japan 35
United Kingdom 35
Canada 28
Denmark 24
Germany 22
Italy 21
Taiwan 20
Israel 19
United States|Canada 15
Korea, Republic of 14
Spain 14
Netherlands 13
India 11
Belgium 9
Iran, Islamic Republic of 7
Norway 7
Sweden 7
Australia 6
Mexico 6
Switzerland 6
Brazil 5
Egypt 5
Hong Kong 5
Singapore 5
United States|Canada|Puerto Rico 5
Thailand 4
United States|India 4
Finland 3
Pakistan 3
Russian Federation 3
Turkey 3
Austria|Belarus|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Poland|Serbia|Slovakia|Slovenia|Spain|Ukraine|United Kingdom 2
China|Korea, Republic of|Philippines|Taiwan 2
Czechia 2
Denmark|Sweden 2
Greece 2
Ireland 2
Jordan 2
United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Croatia|Czechia|Egypt|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 2
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Croatia|Czechia|Estonia|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Lebanon|Lithuania|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Switzerland|Turkey|Ukraine|United Kingdom 2
United States|Argentina|Australia|Austria|Belgium|Canada|China|Croatia|Czechia|Denmark|France|Germany|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Poland|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 2
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain 2
United States|Bulgaria|Canada|Hungary|Latvia|Mexico|Poland|Russian Federation|Serbia|Switzerland|Ukraine 2
United States|Bulgaria|Georgia|Germany|Greece|Hungary|Ireland|Israel|Italy|Moldova, Republic of|Netherlands|Poland|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 2
United States|Canada|Israel 2
United States|Puerto Rico 2
Argentina|Belgium|Brazil|Canada|Chile|Czech Republic|Estonia|Hungary|Italy|Russian Federation|Singapore|South Africa|Spain|Sweden 1
Australia|Belgium|Czech Republic|Denmark|France|Germany|Hungary|Israel|Italy|Poland|Russian Federation|South Africa|Spain|Sweden|United Kingdom 1
Australia|Belgium|Estonia|France|Israel|Italy|Latvia|Lithuania|Poland|Romania|Russian Federation|Slovakia|Sweden|Ukraine|United Kingdom 1
Australia|Bulgaria|Czechia|Estonia|Hungary|India|Italy|Korea, Republic of|Latvia|Malaysia|New Zealand|Poland|Romania|Russian Federation|Serbia|South Africa|Turkey|Ukraine 1
Australia|China|Korea, Republic of|Taiwan 1
Austria 1
Austria|Belgium|Canada|Czechia|Denmark|Finland|Germany|Greece|Italy|Lithuania|Norway|Poland|Russian Federation|Spain|Sweden|Ukraine|United Kingdom 1
Austria|Belgium|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Norway|Portugal|Romania|Singapore|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|France|Germany|Italy|Netherlands|Poland|Portugal|Spain|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Netherlands 1
Austria|Belgium|France|Israel|Italy|Netherlands 1
Belarus 1
Belarus|India|Turkey|Ukraine 1
Belgium|Brazil|Chile|Czech Republic|Denmark|France|Hungary|Israel|Italy|Mexico|Netherlands|Poland|Slovakia|South Africa|Spain|Sweden|United Kingdom 1
Belgium|Bulgaria|Croatia|Denmark|Germany|Hungary|Netherlands|Poland|Slovakia|Sweden 1
Belgium|Canada|Germany|Norway|Sweden 1
Belgium|Czech Republic|Denmark|Finland|Germany|Netherlands|Norway|Sweden 1
Belgium|Czech Republic|Denmark|Germany|Norway|Slovakia|Spain 1
Belgium|Czech Republic|Germany|Hungary|Poland|Russian Federation 1
Belgium|Czech Republic|Latvia|Slovakia 1
Belgium|Finland 1
Belgium|Finland|France|Italy|Spain 1
Belgium|France 1
Belgium|France|Greece|Hungary|Poland|Spain 1
Belgium|France|Netherlands|United Kingdom 1
Belgium|Germany|Netherlands|United Kingdom 1
Belgium|Germany|United Kingdom 1
Belgium|Hungary|Netherlands 1
Belgium|Hungary|Slovakia|Spain 1
Belgium|Poland|Spain|United Kingdom 1
Belgium|United States|Argentina|Austria|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Denmark|Egypt|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
Benin 1
Bulgaria 1
Bulgaria|Czechia|Hungary|Latvia|Lithuania|Poland|Ukraine|United Kingdom 1
Bulgaria|Hungary|Poland 1
Bulgaria|United States|Argentina|Australia|Brazil|Colombia|Croatia|Czechia|Greece|Hungary|Latvia|Lithuania|Malaysia|New Zealand|Poland|Russian Federation|Turkey|Ukraine 1
Canada|Belgium|Netherlands|Sweden 1
Canada|Finland|Israel|Italy|Poland|Spain 1
Canada|Sweden|Ukraine|United States|Australia|Austria|Belgium|Bulgaria|Czech Republic|Denmark|France|Germany|Hungary|India|Israel|Japan|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa 1
Canada|United States|Australia|Belgium|Brazil|Czech Republic|France|Germany|India|Ireland|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|South Africa|Switzerland|United Kingdom 1
Central African Republic|Ghana 1
China|Hong Kong 1
China|Japan 1
China|Korea, Republic of 1
Colombia 1
Croatia|Poland|Romania|Russian Federation|Serbia|Spain 1
Cuba 1
Czech Republic 1
Czech Republic|France|Germany|Italy|Poland|United Kingdom 1
Czech Republic|France|Hungary|Italy 1
Czech Republic|Germany|Hungary|Romania|Russian Federation|Serbia 1
Czech Republic|Italy 1
Czechia|France|Germany|Hungary|Italy|Poland|United Kingdom 1
Czechia|France|Italy|Poland|Spain|United Kingdom 1
Czechia|France|Poland 1
Czechia|Netherlands|Poland 1
Denmark|Finland|Netherlands|Norway|Switzerland|United Kingdom 1
Denmark|France 1
Denmark|France|Germany|Poland|United Kingdom 1
Denmark|France|Germany|Spain 1
Denmark|Germany|Netherlands|Norway|Spain|United Kingdom 1
Denmark|Germany|Spain 1
Denmark|Germany|Sweden 1
Denmark|Korea, Republic of|United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czechia|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
Denmark|Sweden|United Kingdom 1
Dominican Republic|Panama 1
France|Greece|Israel|Italy|Korea, Republic of|Serbia 1
France|Israel|Italy 1
France|United States|Belgium|Canada|Colombia|Czechia|Germany|Hungary|India|Ireland|Poland|Romania|South Africa|Spain|United Kingdom 1
Georgia|Germany|Moldova, Republic of|Ukraine 1
Georgia|Moldova, Republic of|Ukraine 1
Germany|Czech Republic|France|Netherlands 1
Germany|Israel|Netherlands|Singapore|Sweden|Switzerland|United Kingdom 1
Germany|Netherlands|Poland|United Kingdom 1
Germany|Poland 1
Germany|United Kingdom 1
Ghana 1
Hungary 1
Iceland 1
India|United States|Australia|Austria|Belgium|Bulgaria|Canada|Czech Republic|Denmark|France|Germany|Hungary|Israel|Japan|Latvia|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Sweden|Ukraine 1
Indonesia 1
Ireland|United Kingdom 1
Israel|Netherlands|Denmark|France|Germany|United States|Austria|Belgium|Canada|Poland 1
Israel|Slovakia|United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
Israel|Spain 1
Israel|United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Italy|Lithuania|Poland|Russian Federation 1
Italy|Poland 1
Italy|Spain 1
Japan|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
Japan|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
Lebanon 1
Netherlands|United Kingdom 1
New Zealand 1
Papua New Guinea 1
Poland 1
Poland|United Kingdom 1
Poland|United States|Argentina|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Hungary|Israel|New Zealand|Norway|Portugal|Spain|Switzerland 1
Portugal 1
South Africa 1
Sweden|United Kingdom 1
Ukraine|Austria|Belgium|Canada|Czech Republic|Denmark|Germany|Greece|Italy|Norway|Poland|Russian Federation|Sweden|United Kingdom 1
Ukraine|Czechia|France|Germany|Hungary|Poland|Russian Federation|Serbia|Spain|Sweden 1
Ukraine|United States|Australia|Belgium|Bulgaria|Canada|France|Germany|Hungary|Israel|Netherlands|Poland|Romania|Russian Federation 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Croatia|Czechia|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Croatia|Czechia|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Croatia|Czechia|Egypt|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Colombia|Croatia|Czechia|Denmark|Estonia|France|Germany|India|Greece|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Turkey|Ukraine|United Kingdom|Vietnam 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czechia|Denmark|France|Germany|Greece|Hungary|United Kingdom|Israel|Italy|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Spain|Switzerland 1
United States|Argentina|Australia|Austria|Belgium|Canada|Croatia|Czechia|Denmark|France|Georgia|Germany|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Moldova, Republic of|Netherlands|Poland|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Croatia|Czechia|Denmark|Estonia|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Czech Republic|Denmark|France|Germany|Hungary|India|Korea, Republic of|Mexico|Netherlands|New Zealand|Peru|Poland|Portugal|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|United Kingdom 1
United States|Argentina|Australia|Brazil|Bulgaria|Estonia|France|Hong Kong|Mexico|Poland|Russian Federation|Serbia|Slovakia|Ukraine 1
United States|Argentina|Australia|Brazil|Germany|Mexico|Poland|Russian Federation|Ukraine 1
United States|Argentina|Australia|Bulgaria|Canada|Czech Republic|Finland|Germany|Indonesia|Korea, Republic of|Mexico|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Slovakia|South Africa|Thailand 1
United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Denmark|Egypt|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Poland|Sweden|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Austria|Brazil|Canada|Czechia|Denmark|Germany|Hungary|Italy|Poland|Slovakia|Spain 1
United States|Argentina|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Estonia|Greece|Hungary|Ireland|Japan|Korea, Republic of|Lebanon|Mexico|New Zealand|Portugal|Slovakia|Spain|Switzerland|Turkey|Ukraine 1
United States|Australia 1
United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Korea, Republic of|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|France|Germany|Hungary|Italy|Mexico|Netherlands|Poland|South Africa 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Korea, Republic of|Latvia|Lithuania|New Zealand|Poland|Romania|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Latvia|Lithuania|New Zealand|Poland|Romania|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|Estonia|France|Germany|Greece|Hungary|Italy|Latvia|Netherlands|Norway|Poland|Russian Federation|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Hungary|Israel|Japan|New Zealand|Poland|Slovakia|Spain|United Kingdom 1
United States|Australia|Austria|Brazil|Croatia|Czechia|Germany|Israel|Italy|Japan|Lithuania|Netherlands|Poland|Romania|Russian Federation|Serbia|South Africa|United Kingdom 1
United States|Australia|Belarus|Belgium|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|Estonia|France|Georgia|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Moldova, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belarus|Belgium|Bulgaria|Canada|Chile|Croatia|Czechia|Estonia|Georgia|Hungary|India|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine 1
United States|Australia|Belarus|Bulgaria|Canada|Chile|Colombia|Croatia|Czech Republic|Denmark|Finland|Germany|Hungary|India|Italy|Poland|Russian Federation|Ukraine 1
United States|Australia|Belgium|Bulgaria|Canada|Greece|Hungary|Israel|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Slovakia|Ukraine 1
United States|Australia|Belgium|Canada|Czech Republic|Germany|Hungary|Israel|New Zealand|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Denmark|France|Georgia|Hungary|Japan|Lithuania|Moldova, Republic of|Netherlands|Poland|Romania|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Poland|Russian Federation|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Germany|Hungary|Israel|Korea, Republic of|Malaysia 1
United States|Australia|Belgium|Canada|Czechia|Germany|Hungary|Israel|New Zealand|Spain|United Kingdom 1
United States|Australia|Belgium|Germany|Israel|Italy|Korea, Republic of|Saudi Arabia|Serbia|Spain|Turkey 1
United States|Australia|Bulgaria|Canada|Czechia|France|Germany|Hungary|Italy|Netherlands|New Zealand|Poland|Russian Federation|Ukraine 1
United States|Australia|Bulgaria|Canada|France|Georgia|Germany|Greece|Hungary|Israel|Japan|Korea, Republic of|Poland|Portugal|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine 1
United States|Australia|Bulgaria|Hungary|Italy|Japan|Poland|Russian Federation|Slovakia|Spain|Thailand|Turkey 1
United States|Australia|New Zealand|South Africa 1
United States|Australia|Poland|Slovakia|United Kingdom 1
United States|Austria|Belgium|Canada|Czech Republic|Germany|Hungary|Italy|Netherlands|Poland|Puerto Rico|Slovakia|Sweden 1
United States|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Netherlands|Poland|Romania|Slovakia|Spain|Switzerland|Ukraine|United Kingdom 1
United States|Austria|Belgium|Canada|Germany|Greece|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|United Kingdom 1
United States|Austria|Belgium|Canada|Germany|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Spain|United Kingdom 1
United States|Austria|Bulgaria|Canada|Czechia|Denmark|Georgia|Germany|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Turkey|Ukraine 1
United States|Austria|Bulgaria|Canada|France|Germany|Hungary|Netherlands|Poland|Romania|Spain 1
United States|Austria|Canada|France|Germany|Italy|Switzerland|United Kingdom 1
United States|Austria|Estonia|Germany|Poland|South Africa|Sweden|United Kingdom 1
United States|Belarus|Bosnia and Herzegovina|Bulgaria|Croatia|Czechia|Netherlands|North Macedonia|Poland|Portugal|Romania|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 1
United States|Belarus|Bosnia and Herzegovina|Croatia|Georgia|Hungary|Moldova, Republic of|Poland|Russian Federation|Serbia|Ukraine 1
United States|Belarus|Bulgaria|Canada|France|Germany|Hungary|Ireland|Israel|Italy|Poland|Romania|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 1
United States|Belarus|Canada|Croatia|Czech Republic|Estonia|Hungary|Latvia|Lithuania|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Ukraine 1
United States|Belgium|Brazil|France|Israel|Italy|Korea, Republic of|Netherlands|Poland|Spain|Taiwan 1
United States|Belgium|Bulgaria|Canada|Czech Republic|France|Germany|Hungary|Netherlands|Poland|Russian Federation|Ukraine 1
United States|Belgium|Canada 1
United States|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Belgium|Canada|Denmark|Netherlands 1
United States|Belgium|Canada|France|Germany|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom 1
United States|Belgium|Canada|France|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom 1
United States|Belgium|Canada|Germany|Hungary|Italy|Slovakia|Sweden 1
United States|Belgium|Canada|Germany|Netherlands|United Kingdom 1
United States|Belgium|Canada|Hungary 1
United States|Belgium|Canada|Hungary|Moldova, Republic of|Netherlands|Romania 1
United States|Belgium|Czech Republic|India|Poland|Russian Federation|Slovakia|Ukraine|United Kingdom 1
United States|Belgium|Italy|Korea, Republic of|Netherlands|Poland 1
United States|Brazil|Canada|Czechia|Denmark|Germany|Hungary|India|Israel|Italy|Mexico|Poland|Slovakia|South Africa|Ukraine 1
United States|Bulgaria|Canada|Czechia|Estonia|France|India|Korea, Republic of|Netherlands|Poland|Russian Federation|Serbia|Slovakia|South Africa|Ukraine|United Kingdom 1
United States|Bulgaria|Canada|Czechia|Estonia|Hungary|Latvia|Lithuania|Poland|Russian Federation|Ukraine 1
United States|Bulgaria|Canada|Hungary|Poland|Slovakia 1
United States|Canada|Croatia|Poland|Romania 1
United States|Canada|Czech Republic|Hungary|Latvia|Romania|Russian Federation|Ukraine 1
United States|Canada|Czech Republic|Hungary|Poland|Russian Federation|Slovakia 1
United States|Canada|Czechia|Hungary|Netherlands|Poland|Serbia 1
United States|Canada|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Canada|Hungary|Israel|Poland|Slovakia|United Kingdom 1
United States|Canada|India|Mexico 1
United States|Canada|Israel|Japan|Korea, Republic of 1
United States|Canada|United Kingdom 1
United States|China 1
United States|China|Poland|Puerto Rico|Ukraine 1
United States|Czechia|Hungary 1
United States|Czechia|Hungary|Poland|Romania|Russian Federation|Serbia 1
United States|Denmark|Finland|Ireland|Israel|Slovenia|United Kingdom 1
United States|Denmark|Germany|Poland 1
United States|Denmark|Hungary|Italy|Spain|United Kingdom 1
United States|Estonia|Germany|Poland|South Africa|United Kingdom 1
United States|Georgia|Hungary|Moldova, Republic of|Ukraine 1
United States|Georgia|Moldova, Republic of 1
United States|Germany 1
United States|Germany|Netherlands|Poland|Russian Federation|Sweden|United Kingdom 1
United States|Germany|United Kingdom 1
United States|India|Nepal 1
United States|Japan|Poland|Slovakia|Spain|United Kingdom 1
United States|Lithuania|Poland|Slovakia 1
United States|Netherlands Antilles 1
United States|New Zealand 1
United States|Russian Federation|Ukraine 1
Uruguay 1
Vietnam 1
Zambia 1

Sites per Study

Site_count Study_Count
1 505
2 69
3 49
4 21
5 18
6 16
7 20
8 15
9 7
10 6
11 9
12 9
13 7
14 3
15 10
16 7
17 6
18 4
19 6
20 6
21 2
22 8
23 6
24 3
25 7
26 5
27 4
28 5
29 1
30 5
31 2
32 3
33 7
34 5
35 2
36 2
37 3
38 3
39 2
40 1
41 2
42 1
43 3
44 2
45 3
47 1
49 1
50 3
51 1
52 2
55 1
56 1
57 1
58 3
59 2
60 2
61 1
62 3
63 3
64 5
65 1
66 2
68 2
69 1
70 1
71 2
72 2
75 1
76 3
77 2
78 1
80 1
81 2
82 1
86 1
88 3
89 1
90 2
92 1
93 1
94 1
95 1
96 1
97 2
99 2
102 2
104 1
105 5
108 2
111 1
114 1
115 1
117 1
119 1
120 1
123 1
125 1
126 1
134 1
135 1
136 1
142 1
144 1
150 1
166 1
173 2
174 1
178 1
182 1
190 1
192 1
195 1
207 1
208 1
210 1
245 2
253 1
262 1
275 1
298 1
305 1
307 1
309 1
323 1
330 1
343 1
372 2
378 1
382 1
409 1
433 1
435 1
463 1
516 1
524 1
586 1
590 1
855 1

Phase

Phase Study_Count
N/A 347
Phase 3 209
Phase 2 190
Phase 4 103
Phase 1 78
Phase 1/Phase 2 43
Phase 2/Phase 3 33
Early Phase 1 7

Number of Arms

Number_of_Arms Count_of_Studies
1 187
2 546
3 118
4 37
5 22
6 10
7 2
8 3
10 4
12 1
14 1
16 1
NA 78

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 12.0 3.0 3.00000 3.00000 1.0000 15.0000 13.0000 1.0000
1st Qu. 16.0 30.0 13.75000 19.00000 43.0000 62.0000 149.7500 52.5000
Median 50.0 68.0 24.00000 34.00000 88.0000 142.0000 326.0000 118.0000
Mean 39.0 288326.2 35.37179 76.30233 117.0374 321.0303 421.4904 487.8544
3rd Qu. 59.5 143.5 47.00000 60.00000 171.0000 408.0000 521.7500 204.5000
Max. 60.0 99999999.0 181.00000 1100.00000 462.0000 2000.0000 3384.0000 30024.0000

Trial Group Type

group_type Group_Count
Experimental 1109
Active Comparator 450
Placebo Comparator 303
Other 112
NA 78
No Intervention 68
Sham Comparator 29

Intervention Model

intervention_model Study_Count
Parallel Assignment 730
Single Group Assignment 224
Crossover Assignment 33
NA 11
Sequential Assignment 10
Factorial Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 778
Prevention 98
Diagnostic 31
Supportive Care 27
Other 26
Basic Science 18
NA 15
Health Services Research 10
Screening 6
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 41
France 13
NA 13
Japan 12
China 11
Korea, Republic of 8
Canada 6
Denmark 4
Spain 4
United Kingdom 4
United States|Canada 4
Germany 3
Austria 2
Belgium 2
Czech Republic 2
Norway 2
Russian Federation 2
Sweden 2
United States|Italy 2
Brazil 1
Côte D’Ivoire 1
Canada|Germany|Ireland|Italy|Netherlands|Poland|Sweden|United Kingdom 1
Colombia 1
Croatia 1
Denmark|France|United States|Argentina|Australia|Austria|Belgium|Canada|Czechia|Germany|Israel|Netherlands|New Zealand|Switzerland|United Kingdom 1
Egypt 1
France|Greece|Italy 1
Greece 1
Hong Kong|Singapore|Taiwan 1
Indonesia 1
Ireland 1
Israel 1
Italy 1
Netherlands 1
Portugal 1
Romania 1
Saudi Arabia 1
Singapore 1
Switzerland 1
Syrian Arab Republic 1
Taiwan|Argentina|China|Colombia|Korea, Republic of|Mexico|Russian Federation|Saudi Arabia|Singapore|Turkey 1
Tunisia 1
United States|Australia|Austria|Belgium|Canada|Croatia|Denmark|France|Germany|Greece|Ireland|Israel|Italy|Mexico|Netherlands|New Zealand|Norway|Puerto Rico|Spain|Sweden|United Kingdom 1
United States|Austria|Belgium|Canada|Croatia|Denmark|Estonia|France|Germany|Greece|Ireland|Israel|Italy|Netherlands|Norway|Portugal|Slovenia|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Canada|Czechia|France|Germany|Greece|Italy|Korea, Republic of|Spain 1

Sites per Study

Site_count Study_Count
1 115
2 5
3 5
4 3
5 1
6 1
8 1
11 1
12 3
15 3
19 1
21 1
23 1
24 1
26 1
30 3
31 1
36 1
46 1
47 2
60 1
61 1
63 1
76 1
80 1
103 1
105 1
108 1
149 1
159 1
287 1
515 1

Enrollment Metrics

Measure Observational
Min 1.0000
1st Qu 59.0000
Median 146.0000
Mean 870.5092
3rd Qu 501.5000
Max 39000.0000

Observation Model

observational_model Study_Count
Cohort 103
Case-Only 25
Case-Control 11
Other 9
Case Control 7
NA 5
Case-Crossover 2
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 124
Retrospective 21
Cross-Sectional 13
Other 5

Registries

Studies by Country

Country Study_Count
United States 9
Netherlands 2
Canada 1
Czechia 1
Germany 1
Greece 1
Korea, Republic of 1
Norway 1
Spain 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 12
2 2
3 1
13 1
14 1
15 1
37 1

Enrollment Metrics

Measure Registries
Min 50.00
1st Qu 260.00
Median 800.00
Mean 11979.74
3rd Qu 5500.00
Max 175000.00

Registry Model

observational_model Study_Count
Cohort 11
Case-Only 4
Other 3
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 17
Cross-Sectional 1
Other 1

Follow-up

target_duration Study_Count
5 Years 4
1 Month 3
1 Year 2
2 Years 2
1 Day 1
12 Months 1
24 Weeks 1
25 Years 1
3 Months 1
4 Months 1
5 Months 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02578004 Risk Factors for Pressure Ulcers https://ClinicalTrials.gov/show/NCT02578004 Completed Centre Hôpital Universitaire Farhat Hached 2014-04-30
NCT02438410 Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02438410 Completed Mayo Clinic 2019-12-04
NCT01688258 New Multiplex Real-time PCR for Genital Ulcer Disease https://ClinicalTrials.gov/show/NCT01688258 Completed University of Zurich 2013-07-31
NCT03939000 Clinical Profile and Laboratory Finding of DFU From Tertiary Hospitals in Bali https://ClinicalTrials.gov/show/NCT03939000 Completed Udayana University 2018-12-31
NCT03370237 Reliability of a Diabetic Foot Ulcer Risk Stratification and Referral Algorithm https://ClinicalTrials.gov/show/NCT03370237 Completed Lawson Health Research Institute 2017-09-22
NCT03824561 Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] https://ClinicalTrials.gov/show/NCT03824561 Recruiting Takeda 2022-01-31
NCT03341559 Spatial Frequency Domain Imaging (SFD) for Assessment of Diabetic Foot Ulcer Development and Healing https://ClinicalTrials.gov/show/NCT03341559 Completed University of Southern California 2019-12-31
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service https://ClinicalTrials.gov/show/NCT03223012 Completed AbbVie 2019-02-28
NCT03214952 Drug Use Surveillance of Vonoprazan for “Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis” https://ClinicalTrials.gov/show/NCT03214952 Completed Takeda 2018-10-31
NCT03214198 Special Drug Use Surveillance of Takecab for “Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use” https://ClinicalTrials.gov/show/NCT03214198 Completed Takeda 2020-04-30
NCT03214094 Special Drug Use Surveillance of Vonoprazan for “Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use” https://ClinicalTrials.gov/show/NCT03214094 Completed Takeda 2019-02-28
NCT03179865 Evaluation of Early Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03179865 Completed Wolfson Medical Center 2020-02-29
NCT03167632 Oral Ulcer Prevalence: Hospital-based Cross-sectional Study https://ClinicalTrials.gov/show/NCT03167632 Completed Cairo University 2015-10-25
NCT03163680 Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers https://ClinicalTrials.gov/show/NCT03163680 Completed Damascus Hospital 2018-05-01
NCT03142113 Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03142113 Completed Universitaire Ziekenhuizen Leuven 2016-12-31
NCT03090139 Sub-optimal Response to Anti-Tumor Necrosis Factor’s in Inflammatory Bowel Disease in Emerging Markets https://ClinicalTrials.gov/show/NCT03090139 Completed Takeda 2018-06-13
NCT03086577 Pain in Chronic Leg- and Foot Ulcers https://ClinicalTrials.gov/show/NCT03086577 Recruiting University College of Southeast Norway 2018-02-21
NCT03070938 PuraPlyâ„¢ Antimicrobial Wound Matrix and Wound Management https://ClinicalTrials.gov/show/NCT03070938 Completed Organogenesis 2017-09-30
NCT03070925 Prospective PuraPlyâ„¢ AM Case Series Study https://ClinicalTrials.gov/show/NCT03070925 Completed Organogenesis 2017-04-30
NCT03063138 Evaluation of 3D Imaging Ulcer Camera https://ClinicalTrials.gov/show/NCT03063138 Completed Odense University Hospital 2017-03-01
NCT03060733 Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects https://ClinicalTrials.gov/show/NCT03060733 Completed DiaSorin Inc. 2018-05-14
NCT03057171 A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA https://ClinicalTrials.gov/show/NCT03057171 Recruiting Yonsei University 2020-04-30
NCT02986724 A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) https://ClinicalTrials.gov/show/NCT02986724 Active, not recruiting Takeda 2020-08-31
NCT02904707 Interest of Skin Graft Pellets in the Management of Ulcers Algic https://ClinicalTrials.gov/show/NCT02904707 Completed Groupe Hospitalier Paris Saint Joseph 2015-05-31
NCT02889913 When Asking the Indication of a Skin Biopsy From a Patient With a Leg Ulcer in Primary Care? https://ClinicalTrials.gov/show/NCT02889913 Completed Groupe Hospitalier Paris Saint Joseph 2015-07-31
NCT02868398 Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab https://ClinicalTrials.gov/show/NCT02868398 Completed Evangelismos Hospital 2020-04-30
NCT02838251 Effects of Compression in Mixed Ulcers https://ClinicalTrials.gov/show/NCT02838251 Completed Groupe Hospitalier Paris Saint Joseph 2016-07-31
NCT02808780 An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02808780 Recruiting Janssen Biotech, Inc. 2031-07-30
NCT02717897 Vitamin D and Disease Activity in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02717897 Completed University of Chicago 2013-05-31
NCT02693730 Phenotyping IBS: Perceptions and Modulations of Visceral Sensations https://ClinicalTrials.gov/show/NCT02693730 Active, not recruiting University of California, Los Angeles 2020-08-31
NCT02674308 Entyvio (Vedolizumab) Long Term Safety Study https://ClinicalTrials.gov/show/NCT02674308 Active, not recruiting Takeda 2021-07-22
NCT02640391 Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02640391 Completed Kyungpook National University Hospital 2018-12-31
NCT02586259 Effectiveness of Cortiment® in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02586259 Completed Ferring Pharmaceuticals 2018-04-05
NCT00001184 Immune Regulation in Ulcerative Colitis or Crohn s Disease https://ClinicalTrials.gov/show/NCT00001184 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03404557 Proteomic Analysis of Crohn’s Disease Macrophages in Response or Not to AIEC https://ClinicalTrials.gov/show/NCT03404557 Completed University Hospital, Clermont-Ferrand 2019-01-18
NCT02738125 Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions https://ClinicalTrials.gov/show/NCT02738125 Active, not recruiting AbbVie 2028-11-20
NCT02506179 Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02506179 Completed AbbVie 2020-02-10
NCT02502552 Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort https://ClinicalTrials.gov/show/NCT02502552 Completed Centre Hospitalier Universitaire de Saint Etienne 2015-10-31
NCT02499263 A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT02499263 Completed AbbVie 2018-09-17
NCT02439372 Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02439372 Completed Asan Medical Center 2016-06-30
NCT02423512 The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness https://ClinicalTrials.gov/show/NCT02423512 Completed Icahn School of Medicine at Mount Sinai 2017-06-13
NCT02423187 Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin https://ClinicalTrials.gov/show/NCT02423187 Completed Eisai Inc. 2017-10-30
NCT02316990 China Survey of Stress Ulcer Bleeding in Critically Ill Neurosurgical Patients https://ClinicalTrials.gov/show/NCT02316990 Completed AstraZeneca 2015-07-31
NCT02274714 Dysmenorrhea in Women With Crohn’s Disease and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02274714 Completed University of Wisconsin, Madison 2017-01-31
NCT02229344 Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea https://ClinicalTrials.gov/show/NCT02229344 Active, not recruiting Janssen Korea, Ltd., Korea 2022-02-22
NCT02149043 Thermography in Surveillance of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02149043 Completed University Hospital Dubrava 2018-01-31
NCT02110862 Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02110862 Completed Odense University Hospital 2013-08-31
NCT02099708 Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs https://ClinicalTrials.gov/show/NCT02099708 Completed Takeda 2014-03-31
NCT02099682 Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin https://ClinicalTrials.gov/show/NCT02099682 Completed Takeda 2014-01-31
NCT01301976 Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01301976 Completed UPECLIN HC FM Botucatu Unesp 2010-03-31
NCT01285973 Evaluation of Integra® Artificial Dermis for the Treatment of Leg Ulcers https://ClinicalTrials.gov/show/NCT01285973 Completed Integra LifeSciences Services 2015-08-31
NCT01282905 Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01282905 Completed KU Leuven NA
NCT01278550 Prevention of Recurrent Ulcer Bleeding in High-risk Users of Low-dose Aspirin https://ClinicalTrials.gov/show/NCT01278550 Completed Chinese University of Hong Kong 2013-03-31
NCT02632929 Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue https://ClinicalTrials.gov/show/NCT02632929 Active, not recruiting Boise VA Medical Center 2019-07-31
NCT02054533 Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02054533 Completed Icahn School of Medicine at Mount Sinai 2017-06-30
NCT01960439 Responsiveness of Endoscopic Evaluation in UC https://ClinicalTrials.gov/show/NCT01960439 Completed University of Western Ontario, Canada 2015-07-31
NCT01947816 Special Investigation in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01947816 Completed AbbVie 2018-02-15
NCT01916161 The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients https://ClinicalTrials.gov/show/NCT01916161 Completed National Health Service, United Kingdom 2016-02-29
NCT01891214 Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT01891214 Completed Rennes University Hospital 2016-04-30
NCT01888588 Risk of Uncomplicated Peptic Ulcer in the General Population https://ClinicalTrials.gov/show/NCT01888588 Completed AstraZeneca 2013-05-31
NCT01852760 Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound https://ClinicalTrials.gov/show/NCT01852760 Completed Lawson Health Research Institute 2015-07-31
NCT01848561 A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT01848561 Recruiting AbbVie 2027-04-06
NCT01814943 The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users https://ClinicalTrials.gov/show/NCT01814943 Completed AstraZeneca 2013-05-31
NCT01798953 Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis https://ClinicalTrials.gov/show/NCT01798953 Completed Sahlgrenska University Hospital, Sweden 2013-02-28
NCT01768858 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01768858 Completed AbbVie 2017-08-13
NCT01729182 Nexium Capsules LDA Specific Clinical Experience Investigation https://ClinicalTrials.gov/show/NCT01729182 Completed AstraZeneca 2017-03-09
NCT01705522 Multimodal Approach in IBD Patients https://ClinicalTrials.gov/show/NCT01705522 Recruiting Clinical Hospital Colentina 2019-09-30
NCT01678300 Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) https://ClinicalTrials.gov/show/NCT01678300 Completed Beth Israel Deaconess Medical Center 2015-11-30
NCT01654783 Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA https://ClinicalTrials.gov/show/NCT01654783 Completed Kyorin Pharmaceutical Co.,Ltd 2014-06-30
NCT01594658 Venous Ulcer Treatment With Foam Versus Conservative Treatment https://ClinicalTrials.gov/show/NCT01594658 Completed Hospital Occidente de Kennedy 2012-02-29
NCT01591486 Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT01591486 Completed Chinese University of Hong Kong 2013-02-28
NCT01562600 Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation https://ClinicalTrials.gov/show/NCT01562600 Completed AstraZeneca 2015-08-27
NCT01551667 Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds https://ClinicalTrials.gov/show/NCT01551667 Completed Centre Hospitalier Universitaire de Nīmes 2016-03-31
NCT01517607 Mesalazine (PENTASA®) in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01517607 Completed Ferring Pharmaceuticals 2013-12-31
NCT01517594 Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01517594 Completed Ferring Pharmaceuticals 2013-06-30
NCT01468090 Disease Course in an IBD Cohort in the Era of Biological Treatment https://ClinicalTrials.gov/show/NCT01468090 Completed Hvidovre University Hospital 2014-06-30
NCT01467609 PillCam Colon Capsule Endoscopy for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01467609 Completed Shanghai Jiao Tong University School of Medicine 2010-07-31
NCT01435525 Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation https://ClinicalTrials.gov/show/NCT01435525 Completed AstraZeneca 2014-03-31
NCT01434485 Nexium Capsules Clinical Experience Investigation https://ClinicalTrials.gov/show/NCT01434485 Completed AstraZeneca 2014-03-31
NCT01387698 Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01387698 Completed Ferring Pharmaceuticals 2015-10-31
NCT01363453 User Surveillance in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01363453 Completed Ferring Pharmaceuticals 2008-05-31
NCT04447170 Laparoscopic Versus Open Repair of Peptic Ulcer Perforation https://ClinicalTrials.gov/show/NCT04447170 Enrolling by invitation University of Roma La Sapienza 2020-12-31
NCT04272307 MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach. https://ClinicalTrials.gov/show/NCT04272307 Recruiting University Hospital, Bordeaux 2021-02-28
NCT04249661 Differential Effects of Bacteria Colonising Venous Leg Ulcers on Pain and Healing Rates https://ClinicalTrials.gov/show/NCT04249661 Recruiting University Hospital of Limerick 2021-01-09
NCT03416049 The Effects of Pulsed Elelectro-Magnetic Fields (“PEMF”) in the Treatment of Venous Stasis Leg Ulcers https://ClinicalTrials.gov/show/NCT03416049 Recruiting PEMF Systems, Inc. 2020-06-01
NCT04211194 Registry for Upper Gastrointestinal Bleeding https://ClinicalTrials.gov/show/NCT04211194 Recruiting AdventHealth 2020-12-31
NCT04197973 Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC Patients https://ClinicalTrials.gov/show/NCT04197973 Recruiting Keimyung University Dongsan Medical Center 2020-06-20
NCT04148274 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04148274 Recruiting ProgenaBiome 2023-03-31
NCT04131530 Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence https://ClinicalTrials.gov/show/NCT04131530 Recruiting Shandong University 2019-12-31
NCT03955289 Treatment of Foot and Leg Ulcers Using a Laser https://ClinicalTrials.gov/show/NCT03955289 Completed University of Texas Southwestern Medical Center 2019-01-30
NCT03952364 The PRECIOUS Study: Predicting Crohn’s & ColitIs Outcomes in the United States https://ClinicalTrials.gov/show/NCT03952364 Recruiting PredictImmune Ltd 2021-06-30
NCT03952195 Complications and Outcomes of Pouch Excision https://ClinicalTrials.gov/show/NCT03952195 Completed Icahn School of Medicine at Mount Sinai 2017-04-01
NCT03947931 Russian Extremely Severe Ulcerative Colitis Study https://ClinicalTrials.gov/show/NCT03947931 Recruiting State Scientific Centre of Coloproctology, Russian Federation 2021-06-20
NCT03942861 Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol. https://ClinicalTrials.gov/show/NCT03942861 Recruiting Copenhagen University Hospital at Herlev 2020-08-21
NCT03907631 Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC) https://ClinicalTrials.gov/show/NCT03907631 Recruiting Hull University Teaching Hospitals NHS Trust 2020-09-01
NCT03912467 Prevalence of Pressure Ulcers Among Critically Ill Patients and Factors Associated With Their Occurrence in the ICU https://ClinicalTrials.gov/show/NCT03912467 Completed French Society for Intensive Care 2017-06-01
NCT03884439 Infliximab Biosimilar “Pfizer” Drug Use Investigation (Crohn’s Disease or Ulcerative Colitis) https://ClinicalTrials.gov/show/NCT03884439 Recruiting Pfizer 2023-03-13
NCT03839680 Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03839680 Recruiting Centre Hospitalier Universitaire de Besancon 2019-04-15
NCT03808506 Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03808506 Recruiting Lawson Health Research Institute 2021-06-30
NCT03802214 Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)Therapy https://ClinicalTrials.gov/show/NCT03802214 Recruiting Stanford University 2021-12-31
NCT03788824 Evaluation of Inflammation Activity in Ulcerative Colitis by pCLE https://ClinicalTrials.gov/show/NCT03788824 Recruiting Shandong University 2018-12-31
NCT03782727 ObservAtional Study to Investigate Surgical Site Infection in Ulcerated Skin Cancers https://ClinicalTrials.gov/show/NCT03782727 Completed Cardiff and Vale University Health Board 2020-05-31
NCT03773445 Golimumab Trough Levels in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03773445 Recruiting Hospital San Carlos, Madrid 2019-10-31
NCT03765450 Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03765450 Recruiting Robarts Clinical Trials Inc. 2019-12-31
NCT03747068 The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease. https://ClinicalTrials.gov/show/NCT03747068 Completed HaEmek Medical Center, Israel 2015-10-09
NCT03710486 A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn’s Disease (CD) Participants https://ClinicalTrials.gov/show/NCT03710486 Recruiting Takeda 2021-09-30
NCT03698812 A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03698812 Recruiting Nanfang Hospital of Southern Medical University 2020-09-30
NCT03689673 Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT03689673 Active, not recruiting Ipsen 2020-12-31
NCT03669822 Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) https://ClinicalTrials.gov/show/NCT03669822 Recruiting Johns Hopkins University 2020-12-31
NCT03643211 Xeljanz Special Investigation for Long-term Use in UC Patients https://ClinicalTrials.gov/show/NCT03643211 Active, not recruiting Pfizer 2022-01-05
NCT03589183 Gut Microbiome in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03589183 Recruiting Kyunghee University Medical Center 2028-03-31
NCT03578692 Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC) https://ClinicalTrials.gov/show/NCT03578692 Completed Nanjing PLA General Hospital 2018-01-31
NCT03549988 Pro-active Fecal Calprotectin Monitoring PROMOTE-UC https://ClinicalTrials.gov/show/NCT03549988 Recruiting University of British Columbia 2020-06-30
NCT03501758 Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound https://ClinicalTrials.gov/show/NCT03501758 Recruiting Haukeland University Hospital 2023-12-30
NCT01376414 H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department https://ClinicalTrials.gov/show/NCT01376414 Completed George Washington University 2014-08-31
NCT03460847 Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa https://ClinicalTrials.gov/show/NCT03460847 Recruiting Medical University of Graz 2020-03-31
NCT03452501 Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients https://ClinicalTrials.gov/show/NCT03452501 Active, not recruiting Hikma Pharmaceuticals LLC 2020-06-30
NCT03440528 Using of Irradiated Amnion Dressing for the Treatment of Skin Ulcer https://ClinicalTrials.gov/show/NCT03440528 Completed Egyptian Atomic Energy Authority 2018-09-30
NCT01199536 Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers https://ClinicalTrials.gov/show/NCT01199536 Completed AstraZeneca 2013-11-30
NCT01169207 Johns Hopkins Crohn’s Disease and Ulcerative Colitis Study https://ClinicalTrials.gov/show/NCT01169207 Active, not recruiting Johns Hopkins University 2020-12-31
NCT01274767 Prevention of Recurrent Ulcer Bleeding in High-risk Aspirin Users Who Are Not Infected With Helicobacter Pylori https://ClinicalTrials.gov/show/NCT01274767 Completed Chinese University of Hong Kong 2010-06-30
NCT01104753 A Study of Pentasa in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01104753 Completed Ferring Pharmaceuticals 2010-10-31
NCT01091558 Study of Effects of L-Arginine in Colitis and Colon Cancer https://ClinicalTrials.gov/show/NCT01091558 Completed Vanderbilt University Medical Center 2011-12-31
NCT01041196 Perforated Marginal Ulcer After Gastric Bypass https://ClinicalTrials.gov/show/NCT01041196 Completed University of California, San Francisco 2009-01-31
NCT01040416 Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass https://ClinicalTrials.gov/show/NCT01040416 Completed University of California, San Francisco 2009-12-31
NCT01032525 Monroe County Inflammatory Bowel Disease (IBD) Registry https://ClinicalTrials.gov/show/NCT01032525 Completed University of Rochester 2013-05-31
NCT01041079 Chronic Marginal Ulcers After Gastric Bypass https://ClinicalTrials.gov/show/NCT01041079 Completed University of California, San Francisco 2009-12-31
NCT00961948 Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00961948 Completed Mayo Clinic 2013-02-28
NCT00917514 An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen https://ClinicalTrials.gov/show/NCT00917514 Completed Medicpen AB 2010-02-28
NCT00900029 Safety Follow-Up to HP 802-247-09-015 https://ClinicalTrials.gov/show/NCT00900029 Completed Healthpoint 2011-10-31
NCT03479242 Diabetic Foot Ulcer Recurrence: Pilot Study https://ClinicalTrials.gov/show/NCT03479242 Recruiting Indiana University 2021-12-31
NCT04075669 Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples https://ClinicalTrials.gov/show/NCT04075669 Recruiting Fakultas Kedokteran Universitas Indonesia 2020-06-30
NCT03957447 Treat Early and Broad: Thermotherapy of Buruli Ulcer Integrated Into WHOrecommended Wound Management in West Africa https://ClinicalTrials.gov/show/NCT03957447 Recruiting University Hospital Heidelberg 2021-06-01
NCT03827902 Diabetic Foot Ulcer and Wound Infection https://ClinicalTrials.gov/show/NCT03827902 Recruiting University of Texas Southwestern Medical Center 2020-05-31
NCT03863054 An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROXâ„¢) on the Rates of Healing of Chronic Diabetic Foot Ulcers https://ClinicalTrials.gov/show/NCT03863054 Recruiting Singapore General Hospital 2020-06-30
NCT03060746 Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects https://ClinicalTrials.gov/show/NCT03060746 Completed DiaSorin Inc. 2018-05-03
NCT02577120 Wound Healing Endpoint and Recurrence https://ClinicalTrials.gov/show/NCT02577120 Recruiting Indiana University 2020-12-31
NCT02581098 miR-200b & miR-21 in Diabetic Wounds https://ClinicalTrials.gov/show/NCT02581098 Recruiting Indiana University 2020-12-31
NCT02261636 Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment https://ClinicalTrials.gov/show/NCT02261636 Completed Ferring Pharmaceuticals 2019-01-14
NCT02245802 Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic Ulcers https://ClinicalTrials.gov/show/NCT02245802 Completed Chinese University of Hong Kong 2012-04-30
NCT02170207 Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions] https://ClinicalTrials.gov/show/NCT02170207 Completed Takeda 2010-03-31
NCT01241266 China Survey of Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT01241266 Completed AstraZeneca 2011-07-31
NCT03535649 A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants https://ClinicalTrials.gov/show/NCT03535649 Completed Takeda 2018-12-18
NCT00780507 Fecal Biomarker Study for Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00780507 Completed Warner Chilcott 2009-07-31
NCT00759889 Obtaining and Storing Standard of Care Wound Biopsies for Immediate or Future Wound-Related Scientific Study https://ClinicalTrials.gov/show/NCT00759889 Completed Southwest Regional Wound Care Center 2018-12-30
NCT00710489 Potential Research Study Participant Registry https://ClinicalTrials.gov/show/NCT00710489 Completed University of California, Davis 2018-09-05
NCT00709631 Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers https://ClinicalTrials.gov/show/NCT00709631 Completed Assistance Publique - Hôpitaux de Paris 2009-06-30
NCT00705484 European Safety Registry in Ulcerative Colitis (P04808) https://ClinicalTrials.gov/show/NCT00705484 Completed Merck Sharp & Dohme Corp. 2016-10-20
NCT00617916 Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers https://ClinicalTrials.gov/show/NCT00617916 Completed HyperMed 2008-09-30
NCT00604422 Evaluation of the PillCamâ„¢ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00604422 Completed Medtronic - MITG 2010-02-28
NCT00606346 A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00606346 Active, not recruiting Janssen Biotech, Inc. 2037-11-15
NCT00587236 Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis https://ClinicalTrials.gov/show/NCT00587236 Completed Mayo Clinic 2010-08-31
NCT00522002 CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study https://ClinicalTrials.gov/show/NCT00522002 Completed George Washington University 2010-06-30
NCT00474097 Follow-Up Phone Calls After Colorectal Surgery https://ClinicalTrials.gov/show/NCT00474097 Completed University Hospitals Cleveland Medical Center 2007-12-31
NCT00463619 Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00463619 Completed Heidelberg University 2010-04-30
NCT00403923 Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00403923 Completed University Hospitals, Leicester 2007-06-30
NCT00405834 A Pilot Study of the Envision® Surface https://ClinicalTrials.gov/show/NCT00405834 Completed Hill-Rom NA
NCT00405795 Envision® Surface Evaluation https://ClinicalTrials.gov/show/NCT00405795 Completed Hill-Rom NA
NCT00274209 Chromoendoscopy for Ulcerative Colitis Surveillance https://ClinicalTrials.gov/show/NCT00274209 Completed Indiana University 2011-11-30
NCT00222378 Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00222378 Completed University of Miami 2012-06-30
NCT00207688 A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT00207688 Completed Janssen Research & Development, LLC 2015-09-09
NCT00153712 Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers https://ClinicalTrials.gov/show/NCT00153712 Completed Chinese University of Hong Kong 2009-07-31
NCT00013286 A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk https://ClinicalTrials.gov/show/NCT00013286 Completed VA Office of Research and Development NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03251118 A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03251118 Recruiting Target PharmaSolutions, Inc. 2025-07-31
NCT03824418 The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03824418 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2018-05-09
NCT03367897 Bleeding Ulcer and Erosions Study “BLUE Study” https://ClinicalTrials.gov/show/NCT03367897 Completed Ostfold Hospital Trust 2017-12-31
NCT03286452 The RESPOND Registry https://ClinicalTrials.gov/show/NCT03286452 Completed Organogenesis 2018-07-15
NCT02813161 The Diabetic Foot Ulcer Registry https://ClinicalTrials.gov/show/NCT02813161 Recruiting U.S. Wound Registry 2025-01-31
NCT02813187 Venous Leg Ulcer and Lymphedema Registry https://ClinicalTrials.gov/show/NCT02813187 Enrolling by invitation U.S. Wound Registry 2025-05-31
NCT02798055 Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis https://ClinicalTrials.gov/show/NCT02798055 Completed Elpen Pharmaceutical Co. Inc. 2019-06-30
NCT02463500 UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository https://ClinicalTrials.gov/show/NCT02463500 Recruiting University of Texas Southwestern Medical Center 2021-01-31
NCT02326155 To Evaluate the Safety and Efficacy of Remsimaâ„¢ in Patients With Crohn’s Disease (CD) or Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02326155 Recruiting Celltrion 2020-06-30
NCT02308917 Canadian Children Inflammatory Bowel Disease Network (CIDsCANN) https://ClinicalTrials.gov/show/NCT02308917 Recruiting The Hospital for Sick Children 2023-12-31
NCT02280733 A Real World, Observational Registry of Chronic Wounds and Ulcers https://ClinicalTrials.gov/show/NCT02280733 Recruiting U.S. Wound Registry 2025-01-31
NCT03257254 Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU) https://ClinicalTrials.gov/show/NCT03257254 Active, not recruiting Provensis Ltd 2020-05-31
NCT02152904 Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study https://ClinicalTrials.gov/show/NCT02152904 Completed Incheon St.Mary’s Hospital 2015-12-31
NCT02130349 IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. https://ClinicalTrials.gov/show/NCT02130349 Recruiting Maastricht University Medical Center 2020-12-31
NCT02047084 Comparison of Human Allograft to Apligraf for Venous Leg Ulcers https://ClinicalTrials.gov/show/NCT02047084 Enrolling by invitation Solsys Medical LLC 2019-12-31
NCT04032756 Tofacitinib Registry of Patients With Ulcerative Colitis in Germany https://ClinicalTrials.gov/show/NCT04032756 Recruiting Ced Service GmbH 2023-03-31
NCT03872726 Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03872726 Recruiting Corporacion Parc Tauli 2019-05-30
NCT03772145 Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study https://ClinicalTrials.gov/show/NCT03772145 Enrolling by invitation University of North Carolina, Chapel Hill 2020-12-31
NCT03884634 Efficacy of the Dabir Surfaces Micropressure Overlay for Decubitus Ulcer Prevention During Cardiac Surgery https://ClinicalTrials.gov/show/NCT03884634 Recruiting The Cleveland Clinic 2021-02-28